Muhammed Majeed Selected Research

Curcumin

11/2022	Effect of Curcumin on Glycaemic and Lipid Parameters in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
7/2022	Recent advances in nanogold as a promising nanocarrier for curcumin delivery.
6/2022	The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial.
4/2022	Polymeric nanomicelles of curcumin: Potential applications in cancer.
4/2022	Immunomodulatory effects of curcumin in systemic autoimmune diseases.
3/2022	Curcumin nanofibers: A novel approach to enhance the anticancer potential and bioavailability of curcuminoids.
3/2022	Investigation of the Effect of Curcumin on Protein Targets in NAFLD Using Bioinformatic Analysis.
1/2022	Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials.
1/2022	Impact of Curcumin on Hepatic Low-Density Lipoprotein Uptake.
1/2022	PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muhammed Majeed Research Topics

Disease

34	Neoplasms (Cancer) 07/2022 - 10/2012
17	Inflammation (Inflammations) 04/2022 - 12/2015
9	COVID-19 06/2022 - 11/2020
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2017
7	Infections 04/2022 - 01/2019
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2017
4	Pain (Aches) 06/2022 - 10/2016
4	Non-alcoholic Fatty Liver Disease 03/2022 - 10/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2015
4	Atherosclerosis 01/2022 - 01/2017
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2019
4	Obesity 01/2022 - 10/2015
4	Dyslipidemias (Dyslipidemia) 01/2022 - 08/2017
4	Neoplasm Metastasis (Metastasis) 08/2019 - 10/2017
3	Insulin Resistance 10/2022 - 10/2016
3	Breast Neoplasms (Breast Cancer) 03/2022 - 08/2013
3	Cytokine Release Syndrome 01/2022 - 01/2022
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2019
3	Body Weight (Weight, Body) 07/2018 - 01/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016 - 12/2015
2	Fibrosis (Cirrhosis) 03/2022 - 01/2020
2	Cardiotoxicity 01/2022 - 04/2020
2	Weight Gain 01/2022 - 10/2015
2	Carcinogenesis 01/2022 - 10/2018
2	Wounds and Injuries (Trauma) 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2021 - 02/2017
2	Ischemia 08/2020 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 08/2020 - 01/2019
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019 - 01/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2019
2	Acne Vulgaris 01/2019 - 09/2018
2	Leukemia 01/2019 - 10/2012
2	Heart Failure 01/2018 - 02/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 10/2022
1	Headache (Headaches) 06/2022
1	Dyspnea (Shortness of Breath) 06/2022
1	Pharyngitis (Sore Throat) 06/2022
1	Muscle Weakness 06/2022
1	Cough 06/2022
1	Autoimmune Diseases (Autoimmune Disease) 04/2022
1	Neuroinflammatory Diseases 01/2022
1	Multiple Organ Failure (MODS) 01/2022

Drug/Important Bio-Agent (IBA)

52	CurcuminIBA 11/2022 - 10/2012
13	DiarylheptanoidsIBA 01/2022 - 02/2013
11	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2014
9	CytokinesIBA 03/2022 - 08/2016
8	AntioxidantsIBA 01/2022 - 12/2015
7	EnzymesIBA 01/2022 - 01/2017
6	LipidsIBA 11/2022 - 08/2017
6	piperineIBA 06/2022 - 12/2015
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2018
6	PhytochemicalsIBA 01/2021 - 10/2016
5	Therapeutic UsesIBA 01/2021 - 01/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2018
4	calebin-AIBA 03/2020 - 01/2015
4	Transcription Factors (Transcription Factor)IBA 11/2018 - 08/2013
4	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2017
3	Biological ProductsIBA 03/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 03/2022 - 04/2016
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 07/2018
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2019
3	Messenger RNA (mRNA)IBA 01/2021 - 07/2018
3	pterostilbeneIBA 01/2020 - 01/2014
3	PolyphenolsIBA 01/2018 - 02/2017
3	LeptinIBA 12/2017 - 10/2016
3	AdiponectinIBA 12/2017 - 10/2016
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2022 - 01/2022
2	VaccinesIBA 04/2022 - 01/2022
2	SeleniumIBA 04/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 04/2022 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2021
2	StilbenesIBA 01/2022 - 02/2017
2	CholesterolIBA 01/2021 - 10/2016
2	Matrix Metalloproteinases (MMPs)IBA 03/2020 - 01/2017
2	ResveratrolIBA 01/2020 - 02/2017
2	Histones (Histone)IBA 01/2018 - 01/2017
2	AdipokinesIBA 12/2017 - 01/2017
2	Cyclin D1IBA 01/2014 - 08/2013
2	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 08/2013 - 03/2011
2	guggulu extractIBA 08/2013 - 03/2011
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	Capsules (Microcapsules)IBA 06/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2022
1	MicellesIBA 04/2022
1	AntigensIBA 04/2022
1	CaspasesIBA 03/2022
1	3,3',4,5'-tetrahydroxystilbeneIBA 01/2022
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2022
1	InterleukinsIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	scirpusin AIBA 01/2022

Therapy/Procedure

12	Therapeutics 04/2022 - 12/2015
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2019
2	Ayurvedic Medicine (Siddha Medicine) 08/2013 - 03/2011